Genentech's Perjeta wins FDA OK with new approach to breast cancer
September 30, 2013 at 14:26 PM EDT
Genentech Inc.'s Perjeta won accelerated approval Monday from the Food and Drug Administration for a specific type of breast cancer patient...
